Does great brand planning make the difference?

As the hot summer days begin to fade behind us, thoughts start to turn towards next year. Teams are ramping up their planning activities...

Surgeon takes prostate cancer screening to the community

Surgeon Jyoti Shah won’t let men die of embarrassment. Instead of waiting for patients to come to her, she goes out and gets them.

What’s driving a resurgence in primary care pharma representatives?

After flirting with remote detailing, pharma is returning to feet-on-the-ground sales to meet the complex challenges of transforming markets and changing decision makers. Read this...

Two way street: Industry/patient dialogue and its role in market access

How can we make the pharma world more patient centric?

Market access focus: What is the purpose of market access?

Could market access be comparable to the Force in Star Wars, or any Disney, sci-fi, or Harry Potter film?

Market access focus: GM devolution: what has it achieved so far?

Have Greater Manchester achieved anything in three years?

Market access focus: The Biosimilars Battle

Read this article in our Pf Magazine Market Access Special Edition here.  In 2017, Adelphi published research around biosimilars to assess the overall impact on patients,...

Market access focus: Working with the broader health economy

Read this article in our Pf Magazine Market Access Special Edition here.  Pharma really has to start to engage beyond traditional organisations; some companies are...

Market Access focus: The changing landscape of patient access to new medicines

Read this article in our Pf Magazine Market Access Special Edition here.  In a constantly changing market access landscape, industry has a greater range of...

Market Access focus: What does modern market access really mean?

Read this article in our Pf Magazine Market Access Special Edition here.  There is no one definition for modern market access – what does it...

Latest articles

Success in severe eosinophilic asthma drug ‘Fasenra’ trial

AstraZeneca has announced results from the BORA Phase III extension trial evaluating the long-term safety and efficacy of Fasenra (benralizumab) as an add-on maintenance treatment in...

AI drug discovery supported by grant from Innovate UK

Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward as Optibrium™, Intellegens, and Medicines Discovery Catapult secure a grant...

Pharmaceutical job opportunities: Star recruits for ground-breaking product launch

Star, the UK's first choice outsourcing and resourcing provider to the pharmaceutical, medical device and healthcare industries is delighted to announce a new partnership. Through...